Manufacturer
KOTRA PHARMA (M) SDN. BHD.
Contents
Erythromycin ethylsuccinate
Indication
Upper & lower resp tract infections caused by Strep pyogenes & Strep pneumoniae; pertussis caused by Bordetella pertussis; skin & soft tissue infections caused by Strep pyogenes & Strep aureus; otitis media, erythrasma, listeriosis, diphtheria, primary syphillis in patients allergic to penicillin, prophylaxis of endocarditis.
Instruction
Adult 400 mg 6 hrly or 800 mg 12 hrly. Max: 4 g daily.Childn 30-50 mg/kg in divided doses. Childn 2-8 yr 1 g daily in divided doses in severe cases. Infant & childn ≤2 yr 500 mg daily in divided doses.
Drug interaction
Hepatotoxic or ototoxic drugs, cimetidine, carbamazepine, cyclosporine, phenytoin, alfentanil, cisapride, lovastatin, bromocriptine, valproate, terfenadine, astemizole, theophylline, digoxin, ergotamine, midazolam.
Malaysia
